Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0-II) melanoma.
Jake Robert ThompsonAndrea L SmithSerigne N LoNadine A KasparianRobyn Pm SawMbathio DiengLinda SeamanLinda K MartinPascale GuiteraDonna MilneHelen SchmidAnne E CustIris BartulaPublished in: BMJ open (2022)
Ethics approval was granted by the Sydney Local Health District-Royal Prince Alfred Zone (2020/ETH02518), protocol number: X20-0495. Results will be disseminated through peer-reviewed journals, conference presentations, social media and result summaries distributed to interested participants. TRIAL REGISTRATION DETAILS: (ACTRN12621000145808).
Keyphrases
- social media
- healthcare
- early stage
- health information
- public health
- end stage renal disease
- randomized controlled trial
- study protocol
- newly diagnosed
- ejection fraction
- quality improvement
- chronic kidney disease
- palliative care
- clinical trial
- primary care
- south africa
- peritoneal dialysis
- papillary thyroid
- phase iii
- systematic review
- pain management
- lymph node
- machine learning
- open label
- young adults
- neoadjuvant chemotherapy
- chronic pain
- human health
- phase ii